WebDisclosure WebDisclosure
Basculer en Français
11289 Companies
250811 Keywords
179538 Articles
136599 Press releases
Headlines Articles Press releases AndzonBio2 Remove
  1. Home
  2. Companies
  3. AndzonBio2
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/13/2026 at 09:25, 5 months 23 days ago

    AndzonBio2, University of Cambridge, and Cambridge Enterprise Collaborate on Neuroinflammation Therapeutics

    Drug Discovery Collaboration Neurodegenerative Diseases Therapeutic Development Neuroinflammation
  • BRIEF

    published on 05/13/2026 at 09:25, 5 months 23 days ago

    AndzonBio2, l'Université de Cambridge et Cambridge Enterprise collaborent sur des thérapies contre la neuroinflammation.

    Collaboration Maladies Neurodégénératives Développement Thérapeutique Découverte De Médicaments Neuroinflammation
  • PRESS RELEASE

    published on 05/13/2026 at 09:20, 5 months 23 days ago

    AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation

    AndzonBio2 partners with ALBORADA Drug Discovery Institute and Cambridge Enterprise to develop innovative neuroinflammation therapeutics, targeting neurodegenerative diseases like Parkinson's and Alzheimer's
    Therapeutics Neuroinflammation AndzonBio2 ALBORADA Drug Discovery Institute Cambridge Enterprise
    Logo of AndzonBio2
Accesswire
  • Published on 11/05/2026 at 15:20, 13 minutes ago

    MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors

  • Published on 11/05/2026 at 14:31, 1 hour 2 minutes ago

    First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile

  • Published on 11/05/2026 at 14:25, 1 hour 8 minutes ago

    Polaris Renewable Energy Announces Q3 2026 Results

  • Published on 11/05/2026 at 14:20, 1 hour 13 minutes ago

    Polaris Renewable Energy Declares Quarterly Dividend

  • Published on 11/05/2026 at 14:15, 1 hour 18 minutes ago

    Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook

View all ACCESSWIRE
EQS Group
  • Published on 11/05/2026 at 15:10, 22 minutes ago

    Center for Creative Leadership Names Patrick Mullane President and Chief Executive Officer

  • Published on 11/05/2026 at 14:58, 34 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 11/05/2026 at 14:58, 34 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

  • Published on 11/05/2026 at 14:57, 35 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

  • Published on 11/05/2026 at 14:57, 35 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Rotork plc

View all EQS
Les Echos
  • Published on 11/05/2026 at 15:01, 31 minutes ago

    Chiffre d'Affaires du 1er semestre de l'exercice 2026/2027

  • Published on 11/05/2026 at 10:16, 5 hours 16 minutes ago

    Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %

  • Published on 11/05/2026 at 10:16, 5 hours 16 minutes ago

    Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%

  • Published on 11/05/2026 at 07:44, 7 hours 48 minutes ago

    Résultats d’ENGIE 9 mois 2026

  • Published on 11/05/2026 at 07:44, 7 hours 48 minutes ago

    ENGIE 9M 2026 results

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy